Another setting in which ctDNA analysis obtained clinical approval was the early detection of CRC in asymptomatic average risk individuals undergoing screening through the identification of epigenetic changes, including DNA methylation of the septin9 (SEPT9) gene, with the RT‐qPCR approach namely EpiproColon test [64, 65]. Here, SEPTIN9 is linked to colorectal carcinoma.